Cargando…
The cure rate after different treatments for mucosal leishmaniasis in the Americas: A systematic review
BACKGROUND: Mucosal or mucocutaneous leishmaniasis is the most severe form of tegumentary leishmaniasis due to its destructive character and potential damage to respiratory and digestive tracts. The current treatment recommendations are based on low or very low-quality evidence, and pentavalent anti...
Autores principales: | Carvalho, Janaína de Pina, Silva, Sarah Nascimento, Freire, Mariana Lourenço, Alves, Líndicy Leidicy, de Souza, Carolina Senra Alves, Cota, Gláucia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9714886/ https://www.ncbi.nlm.nih.gov/pubmed/36395328 http://dx.doi.org/10.1371/journal.pntd.0010931 |
Ejemplares similares
-
Diagnostic performance of commercially available COVID-19 serology tests in Brazil
por: Cota, Gláucia, et al.
Publicado: (2020) -
Performance differences among commercially available antigen rapid tests for COVID-19 in Brazil
por: Freire, Mariana Lourenço, et al.
Publicado: (2022) -
Estimating direct costs of the treatment for mucosal leishmaniasis in Brazil
por: Carvalho, Janaína de Pina, et al.
Publicado: (2021) -
Cost-effectiveness of serological tests for human visceral leishmaniasis in the Brazilian scenario
por: Freire, Mariana Lourenço, et al.
Publicado: (2020) -
Cost-effectiveness of anti-SARS-CoV-2 antibody diagnostic tests in Brazil
por: de Assis, Tália Santana Machado, et al.
Publicado: (2022)